These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7996386)
1. Hepatobiliary disposition of 3'-azido-3'-deoxythymidine (AZT) in the rat: effect of phenobarbitone induction. Bezek S; Kukan M; Bohov P J Pharm Pharmacol; 1994 Jul; 46(7):575-80. PubMed ID: 7996386 [TBL] [Abstract][Full Text] [Related]
2. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells. Cretton EM; Xie MY; Bevan RJ; Goudgaon NM; Schinazi RF; Sommadossi JP Mol Pharmacol; 1991 Feb; 39(2):258-66. PubMed ID: 1996084 [TBL] [Abstract][Full Text] [Related]
3. Modulation of 3'-azido-3'-deoxythymidine catabolism by probenecid and acetaminophen in freshly isolated rat hepatocytes. Cretton EM; Sommadossi JP Biochem Pharmacol; 1991 Sep; 42(7):1475-80. PubMed ID: 1930271 [TBL] [Abstract][Full Text] [Related]
4. Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes. Pan-Zhou XR; Cretton-Scott E; Zhou XJ; Xie MY; Rahmani R; Schinazi RF; Duchin K; Sommadossi JP Antimicrob Agents Chemother; 1997 Nov; 41(11):2502-10. PubMed ID: 9371357 [TBL] [Abstract][Full Text] [Related]
5. Comparative metabolism of 3'-azido-3'-deoxythymidine in cultured hepatocytes from rats, dogs, monkeys, and humans. Nicolas F; De Sousa G; Thomas P; Placidi M; Lorenzon G; Rahmani R Drug Metab Dispos; 1995 Mar; 23(3):308-13. PubMed ID: 7628294 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys. Cretton EM; Schinazi RF; McClure HM; Anderson DC; Sommadossi JP Antimicrob Agents Chemother; 1991 May; 35(5):801-7. PubMed ID: 1854160 [TBL] [Abstract][Full Text] [Related]
7. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074 [TBL] [Abstract][Full Text] [Related]
8. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes. Haumont M; Magdalou J; Lafaurie C; Ziegler JM; Siest G; Colin JN Arch Biochem Biophys; 1990 Sep; 281(2):264-70. PubMed ID: 2118332 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of thymidine transport by 3'-azido-3'-deoxythymidine and its metabolites. Zimmerman TP; Domin BA; Mahony WB Oncol Res; 1993; 5(12):483-7. PubMed ID: 8086670 [TBL] [Abstract][Full Text] [Related]
10. Glucuronidation of 3'-azido-3'-deoxythymidine: human and rat enzyme specificity. Resetar A; Spector T Biochem Pharmacol; 1989 May; 38(9):1389-93. PubMed ID: 2719717 [TBL] [Abstract][Full Text] [Related]
11. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. Sommadossi JP; Carlisle R; Zhou Z Mol Pharmacol; 1989 Jul; 36(1):9-14. PubMed ID: 2747633 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of mammalian DNA polymerase-associated 3' to 5' exonuclease activity by 5'-monophosphates of 3'-azido-3'-deoxythymidine and 3'-amino-3'-deoxythymidine. Bridges EG; Faraj A; Sommadossi JP Biochem Pharmacol; 1993 Apr; 45(8):1571-6. PubMed ID: 8387298 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evaluation of drug interactions with anti-human immunodeficiency virus drugs. VI. Effect of the calcium channel blocker nimodipine on zidovudine kinetics in monkeys. Gallo JM; Swagler AR; Mehta M; Qian M J Pharmacol Exp Ther; 1993 Jan; 264(1):315-20. PubMed ID: 8423534 [TBL] [Abstract][Full Text] [Related]
14. In vitro glucuronidation of 3'-azido-3'-deoxythymidine by human liver. Role of UDP-glucuronosyltransferase 2 form. Rajaonarison JF; Lacarelle B; De Sousa G; Catalin J; Rahmani R Drug Metab Dispos; 1991; 19(4):809-15. PubMed ID: 1680659 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of 3'-azido-3'-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3'-amino-3'-deoxythymidine. Stagg MP; Cretton EM; Kidd L; Diasio RB; Sommadossi JP Clin Pharmacol Ther; 1992 Jun; 51(6):668-76. PubMed ID: 1611806 [TBL] [Abstract][Full Text] [Related]
16. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8. Darnowski JW; Goulette FA Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649 [TBL] [Abstract][Full Text] [Related]
18. Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Trapnell CB; Klecker RW; Jamis-Dow C; Collins JM Antimicrob Agents Chemother; 1998 Jul; 42(7):1592-6. PubMed ID: 9660989 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells. Weidner DA; Bridges EG; Cretton EM; Sommadossi JP Mol Pharmacol; 1992 Feb; 41(2):252-8. PubMed ID: 1538705 [TBL] [Abstract][Full Text] [Related]
20. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine. Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]